• KGS/USD = 0.01137 0%
  • KZT/USD = 0.00226 0%
  • TJS/USD = 0.09272 -0.11%
  • UZS/USD = 0.00008 0%
  • KGS/USD = 0.01137 0%
  • KZT/USD = 0.00226 0%
  • TJS/USD = 0.09272 -0.11%
  • UZS/USD = 0.00008 0%
  • KGS/USD = 0.01137 0%
  • KZT/USD = 0.00226 0%
  • TJS/USD = 0.09272 -0.11%
  • UZS/USD = 0.00008 0%
  • KGS/USD = 0.01137 0%
  • KZT/USD = 0.00226 0%
  • TJS/USD = 0.09272 -0.11%
  • UZS/USD = 0.00008 0%
  • KGS/USD = 0.01137 0%
  • KZT/USD = 0.00226 0%
  • TJS/USD = 0.09272 -0.11%
  • UZS/USD = 0.00008 0%
  • KGS/USD = 0.01137 0%
  • KZT/USD = 0.00226 0%
  • TJS/USD = 0.09272 -0.11%
  • UZS/USD = 0.00008 0%
  • KGS/USD = 0.01137 0%
  • KZT/USD = 0.00226 0%
  • TJS/USD = 0.09272 -0.11%
  • UZS/USD = 0.00008 0%
  • KGS/USD = 0.01137 0%
  • KZT/USD = 0.00226 0%
  • TJS/USD = 0.09272 -0.11%
  • UZS/USD = 0.00008 0%

Viewing results 1 - 6 of 19

Indian Pharma Makes Changes After Cough Syrup Kills Uzbek Children

The deaths of several children in Uzbekistan caused by Marion Biotech's Dok-1 Max cough syrup have prompted the Indian government to make significant reforms in the pharmaceutical sector. In December 2022 the deaths of 18 children after taking Dok-1 Max were reported, but the cases didn't receive much publicity -- despite Marion Biotech then losing its license to sell that drug in March 2023. Sales of the syrup continued, and in August 2023 details emerged about 65 more child deaths from the same syrup. Local media reported that during the trial prosecutors said that officials had received a $33,000 bribe to not test the drug. As a result, 21 managers and employees of Quramax Medikal LLC, the Pharmaceutical Industry Development Agency and the Indian State Center for Expertise and Standardization of Medicines, Medical Devices and Medical Equipment were put on trial. The Indian Ministry of Health conducted inspections of all pharmaceutical plants in the country and, as it turned out, in addition to a lack of testing of incoming raw materials detected at 162 plants, less than 25% of the existing 8,500 small pharmaceutical plants meet the requirements of WHO international standards. India has introduced new standards in 2024 to which every company operating in the pharmaceutical industry will have to adhere. According to Tafsilar news agency, the new decrees gave large factories no more than six months to bring everything in line with international standards, while smaller factories were given a year.

Uzbekistan: New FEZ to attract investment, pharmaceutical technologies from India

TASHKENT (TCA) — The President of Uzbekistan Shavkat Mirziyoyev has signed a Decree “On the establishment of Andijon-Pharm free economic zone,” the Jahon information agency reported. Continue reading

French company brings innovative pharmaceutical technologies to Kazakhstan

ASTANA (TCA) — French pharmaceutical company Servier and KAZAKH INVEST National Company for Investment Support and Promotion signed an agreement on cooperation in pharmaceutical production. The document was signed by Servier’s EAEU Managing Director Jerome Gavet and KAZAKH INVEST Chairman Saparbek Tuyakbayev, at the Kazakhstan Global Investment Roundtable in Astana on July 3, the Kazakh company said. Continue reading

Kyrgyzstan: healthcare minister under fire for anti-corruption efforts

BISHKEK (TCA) — Kyrgyzstan’s Healthcare Minister Talantbek Batyraliev has come under criticism, especially from Parliament members. Continue reading

Uzbekistan, Korea agree on trade, finance, light-industry, pharmaceutical cooperation

TASHKENT (TCA) — A number of important agreements aimed at expanding economic and trade cooperation have been reached before and during the ongoing state visit of Uzbekistan President Shavkat Mirziyoyev to the Republic of Korea, the Jahon information agency reports. The Ministry for Foreign Trade of Uzbekistan and the Ministry of Trade, Industry and Energy of the Republic of Korea discussed the possibility of establishing a free trade zone and reached agreement on the need to ensure preferential access to the markets of the two countries. In this regard, heads of the ministries adopted a decision on holding the first meeting of the joint working group until the end of this year. The meeting is set to contribute to the preparation of a bilateral Agreement on preferential trade between Uzbekistan and the Republic of Korea. The Export-Import Bank Korea Eximbank and the National Bank of Uzbekistan have signed a loan agreement worth $150 million. The agreement is expected to provide a credit line for financing small business and investment projects involving the acquisition of equipment, goods and services of Korean production. The credit line is set to cover projects in the areas of agriculture, food industry, medicine, production of construction materials, and automotive industry. Before the president’s visit to South Korea, on November 16-18, a delegation of Uzbekengilsanoat light-industry JSC held a number of meetings and negotiations in Seoul. Following meetings with heads of large Korean trading companies Posco Daewoo, Color of Paradise, Solsang International Corp, RATEL E&T co., Ltd, Korea Factory and trading networks Lotte Mart, the parties reached agreements (contracts and protocols of intentions) to export $70 million worth of textile products from Uzbekistan to Korea in 2017-2018. The Agency for development of the pharmaceutical industry under the Ministry of Health of Uzbekistan has reached an agreement on organization of production of highly effective Korean medicines in Uzbekistan. The Korean side will invest $25 million in direct investments. Agreements were reached with such leading Korean companies as Dalim BioTech, Yuhan Corporation and Erae. Special attention was paid to the organization of 7 new pharmaceutical free economic zones in Uzbekistan.

Business delegation from India visits Kazakhstan

ALMATY (TCA) — A delegation of the Indian Federation of Chambers of Commerce and Industry arrived in Almaty to invite Kazakhstan entrepreneurs to expand cooperation, the Atameken National Chamber of Entrepreneurs of Kazakhstan reported on July 24. Continue reading

Start typing to see posts you are looking for.